February 2015 Volume 11, Issue 2

Volume 11, Issue 2 | February 2015

February 2015

In this Issue

Business & Government Policy

Drug Discovery News Placeholder Image

Shire to snap up NPS Pharma for $5.2B

Acquisition is a further step by Shire toward building itself into a leading biotech
Drug Discovery News Placeholder Image

$25-million launch for Vtesse

Company to work with NIH on drugs for Niemann-Pick disease and other life-threatening rare diseases
Drug Discovery News Placeholder Image

Converging on growth

Biogen Idec expands pain portfolio with Covergence expertise, Phase 2 drug candidate
Drug Discovery News Placeholder Image

For your approval

A collection of recent regulatory approvals and actions globally
Drug Discovery News Placeholder Image

On the cutting edge

A roundup of instrumentation, software and other tools and technology news

Research & Development

Drug Discovery News Placeholder Image

Roche teams with Foundation Medicine

Molecular information collaboration leverages companies’ strengths to advance progress of personalized treatments for oncology
Drug Discovery News Placeholder Image

Immune checkpoint strides

Research indicates cancer immunotherapies have potential for a long-lasting response to treatment
Drug Discovery News Placeholder Image

Sequencing for success

Roche acquires Bina Technologies, enters genomic informatics market
Drug Discovery News Placeholder Image

Adding to the mix

Rockland ventures into aptamer market with SBIR funding
Drug Discovery News Placeholder Image

Living Lab expands

FEI and OHSU install complete correlative microscopy workflow in newly built collaborative science facility

Special Reports

Drug Discovery News Placeholder Image

Signs of intelligent biomarkers

Lots of genomics data, but how much knowledge?

Feature

Drug Discovery News Placeholder Image

Pittcon 2015 provides breadth and depth

Pittcon maintains its reach into pharma, biotech and life sciences while adding a new focus on a younger demographic

Q&A

Drug Discovery News Placeholder Image

Q&A: Opioid addiction and the quest for a solution

DDNews talks with Dr. Mark A. Sirgo, of BioDelivery Sciences Inc. about how his company and its collaborator Endo Pharmaceuticals are working together to help resolve the problem of addiction to narcotic painkillers

Editor's Focus

Drug Discovery News Placeholder Image

Entering the 21st century…precisely?

Congress and President Obama are both talking big talk about stepping into the 21st century boldly in terms of healthcare, but what are they really telling us and what will they actually do?

Commentary

Drug Discovery News Placeholder Image

The tyranny of averages

There are plenty of numbers in the life-sciences, pharma and the like, but we need to look for more meaning and context for them
Drug Discovery News Placeholder Image

A grad student Q&A with Peter T. Kissinger

What 'Dear Abby' did for relationship advice and other wisdom about life, DDNews columnist Peter T. Kissinger seeks to do with a Q&A-style piece aimed at answering some of the (presumably) pressing concerns of grad students and postdocs

Clinical Trials

Drug Discovery News Placeholder Image

Taking aim at AT

Alnylam reports encouraging Phase 1 results for hemophilia RNAi therapeutic
Drug Discovery News Placeholder Image

A new class of opioid therapeutic

Cara Therapeutics reports positive top-line data from Phase 1b trial of IV CR845 in dialysis patients with uremic pruritus
Drug Discovery News Placeholder Image

Studies in motion

Auspex scores in three clinical trials involving SD-809
Drug Discovery News Placeholder Image

Arresting cardiac risks

FDA gives go-ahead for earlier cardiac safety testing
Drug Discovery News Placeholder Image

Real talk on RASAL2

GIS study finds RASAL2 to be upregulated in triple-negative or estrogen receptor-negative breast cancer tumors

Discovery

Drug Discovery News Placeholder Image

Enzyme provides an inroad

Scientists at Scripps discover enzyme for treating brain inflammation in patients with PHARC, Parkinson’s, Alzheimer’s, ALS and MS
Drug Discovery News Placeholder Image

Mersana and Takeda expand ADC partnership

Aim is to create novel Fleximer antibody-drug conjugate candidates to include additional oncology-relevant targets
Drug Discovery News Placeholder Image

Exploring Ebola efforts

Kymab to lead a consortium to pursue antibodies against Ebola virus

Preclinical

Drug Discovery News Placeholder Image

Repurposed duo vs. Alzheimer’s

Pharnext’s pleotherapy shows synergistic effects in PXT-864 for Alzheimer’s disease
Drug Discovery News Placeholder Image

Attacking an early MS sign

Collaboration keeps first-in-class neuroprotective agent in acute optic neuritis on track for early clinical trials
Drug Discovery News Placeholder Image

Rebranding and reaching out

Expansion, conference are milestones for Crown Bioscience
Drug Discovery News Placeholder Image

Pharma strikes sweet deal with Hershey company

Cipher pays $500K for assets of Melanovus; expands dermatology pipeline

Diagnostics

Drug Discovery News Placeholder Image

Two deals; one goal

Amarantus expands its reach with acquisition deal and license agreement
Drug Discovery News Placeholder Image

Revolution in immuno-oncology

Intratumoral cancer immunotherapy enhances local delivery and uptake of DNA-based immune-targeting agents
Drug Discovery News Placeholder Image

Massing diagnostic efforts in Massachusetts

Diagnostics For All issues challenge grant for multi-institution Ebola partnership
Drug Discovery News Placeholder Image

First to assess BRCA status

Myriad receives FDA approval on companion diagnostic for Lynparza in ovarian cancer
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
A starry night sky reflected over calm water, symbolizing the discovery of hidden patterns in complex systems.

Technology Guide: Spatial biology techniques

Discover essential strategies and expert insights to navigate the expanding world of spatial biology.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue